The gold standard treatment for cancer in the last few decades has been a combination of surgery – to remove tumours – and chemotherapy and radiotherapy – to kill cancer cells. With the progress of personalised medicine, where identifying specific mutations in the tumour guides treatment selection, there has been increasing success in survival rates.
Read MoreDr Sam Greenall from Hudson Institute’s Centre for Cancer Research has been awarded the inaugural Ethan Davies Fellowship, to develop “dish-grown” tumour cultures that can be used to screen new drug treatments for a rare type of brain cancer. Dr Greenall was announced as the inaugural recipient of the Fellowship at an official launch hosted
Read MoreThe Monash Partners Comprehensive Cancer Consortium’s (MPCCC) Annual Report 2015-2016 is now available for download. (please note: this file is 12MB) Featuring selected highlights of biomedical, translational and clinical cancer research from Monash Comprehensive Cancer Consortium’s (MCCC) partner organisations, alongside the service improvement activities undertaken by the Southern Melbourne Integrated Cancer Service (SMICS) team in
Read MoreThe Monash Partners Comprehensive Cancer Consortium (MPCCC) was joined by over 170 guests at its 2016 Cancer Forum, which was hosted at the Metropolitan Golf Club on 18 October. Chaired by Prof John Zalcberg, Head of Cancer Research at Monash University’s Department of Epidemiology and Preventive Medicine, the 2016 Cancer Forum featured presentations from MPCCC
Read MoreThe Prostate Cancer Summit was held in Melbourne on 25th May this year, gathering 70 multidisciplinary delegates from across Victoria to identify practical and achievable actions that could have a positive impact on patient outcomes. The summit was a call to all with a stake in achieving better outcomes for men with prostate cancer for
Read MoreImproving outcomes for people with Oesophagogastric (OG) cancers is particularly challenging. Chances for early detection are slim and many present at a late stage of disease. Members of OG cancer multidisciplinary teams across Victoria gathered on the 26th of August this year to review variations in care and identify opportunities to improve the outcomes and
Read MoreA psychological support service has been found to help alleviate common fears shared by people who have had melanomas that the potentially deadly skin cancer will return. A trial of 164 patients showed that the number of people who had those fears halved when given three telephone-based support sessions with psychologists. Those that took part
Read MoreResearchers at Hudson Institute of Medical Research are working to establish and pilot an Australian-first service for analysing the most common type of paediatric solid brain cancer tumour, medulloblastoma, to enable more effective treatment for these paediatric brain cancer patients. Involving a collaborative team of researchers and clinicians from Hudson Institute, Monash Health and Monash
Read MoreHudson Institute of Medical Research is pleased to welcome Dr Joseph (Sefi) Rosenbluh as Director of the new Centre of Functional Genomics within the Centre for Cancer Research. Dr Rosenbluh joined the Centre, a new initiative within the Centre for Cancer Research, in October 2016. He has also been appointed as a group leader in
Read MoreTwo post-doctoral research fellows will be welcomed by the Cabrini Monash University Department of Surgery over the coming months, and will provide crucial support to the cancer research activities led by Cabrini in collaboration with Monash University and MPCCC’s clinical partner organisations. Dr Christine Koulis received her PhD from University of Melbourne in 2008 from
Read More